What sector is GENB in?

Generate Biomedicines, Inc. is classified under GICS Health Care (Biotechnology).

What is GENB's last close price?

GENB last closed at $15.57 on 2026-09-24.

GENB

NASDAQNext earnings·Nov 5AnalystsStrong Buy·5+73%

Generate Biomedicines, Inc.

Health Care · Biotechnology

$15.57last close

+23.1%~252d

Price

-3.53% over 1M

4 auto-fib

Thesis

as of 2026-09-23

Clinical-stage generative-biology platform - AI-designed protein therapeutics. 3M net), Phase 3 SOLAIRIA-1/2 testing GB-0895 anti-TSLP in severe asthma. $516M cash post-IPO with ~$80M/qtr burn; runway into 1H 2028. 2M quarterly milestone revenue - most platform value remains back-end-loaded.

•2022 - Amgen collaboration signed: up to $1.9B value, 5 initial + 5 optional protein-therapeutic programs
•Pre-IPO - Novartis collaboration signed: >$1B potential value, AI-designed protein therapeutics
•2026-02-26 - NASDAQ IPO priced: 25M shares at $16 = $400M gross ($369.3M net proceeds)
•2026-02-27 - Day 1 close $12.65 (-21% from IPO price); $300M of proceeds earmarked for GB-0895 Phase 3 completion
•2026-Q1 - Reported $7.2M revenue (vs $8.8M Y/Y), net loss $61.7M (vs $44.3M Y/Y), R&D $57.8M (vs $46.8M Y/Y), operating cash burn $80.4M
•2026-mid - GB-4362 (MMAE neutralizer, FDA Fast Track granted) expected first-patient dosing; oncology indication
•2026-2H - GB-5267 (MUC16 CAR-T) expected first-patient dosing in Phase 1 solid-tumor trial (ovarian initially); Roswell Park Comprehensive Cancer Center partnership
•Snapshot 2026-05-18: price ~$13.01, mcap ~$1.67B (128.2M sh), cash $516.6M, runway into 1H 2028 per company guidance
•Setup tension: ~6.5 quarters of runway vs Phase 3 SOLAIRIA readout dates undisclosed - fundraise risk likely before next major data milestone; Amgen + Novartis partnerships generate only $7.2M/qtr today, most value is milestone-dependent and back-end-loaded; IPO ran $16 → $16.82 → $13, full give-back of the post-IPO pop

Follow $GENB and the AI trade, free.

Each weekday: the scan's ENTER setups with entry, stop and target, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.

No spam. One email per day max. Pro adds Telegram trade alerts and higher AI-assistant limits.

Analyze GENB· interactive tools

Conviction· in 1 watchlist

Top correlated· 252d co-movement

0.42
0.36
0.36
0.33
0.32

Frequently asked questions

What sector is GENB in?: Generate Biomedicines, Inc. is classified under GICS Health Care (Biotechnology).
What is GENB's last close price?: GENB last closed at $15.57 on 2026-09-24.

Key levels

$15.46
0.618 retr of 11.00->22.67 (52w) · 2026-09-24
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
+0.7%
$16.84
0.5 retr of 11.00->22.67 (52w) · 2026-09-24
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
-7.5%
$18.21
0.382 retr of 11.00->22.67 (52w) · 2026-09-24
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
-14.5%
$13.50
0.786 retr of 11.00->22.67 (52w) · 2026-09-24
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
+15.4%

Open full Fib grid →Correlation lookup →🔔 Get Telegram alerts for $GENB →

Facts

Exchange: NASDAQ
Currency: USD
Market cap: $2.12B
Last update: 2026-09-24

Revenue (TTM)$26M

P/E -

P/S80.1×

Net margin0.0%